Life Science Company News

Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates

Read more ››
By: GlobeNewswire - 17 Apr 2024

Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds

Read more ››
By: GlobeNewswire - 17 Apr 2024

Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment

Read more ››
By: GlobeNewswire - 17 Apr 2024

Milestone® Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium

Read more ››
By: GlobeNewswire - 17 Apr 2024

Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise

Read more ››
By: GlobeNewswire - 17 Apr 2024

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01

Read more ››
By: GlobeNewswire - 17 Apr 2024

Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria

Read more ››
By: GlobeNewswire - 17 Apr 2024

Cerevance Presents at 35th Symposium on Medicinal Chemistry in Eastern England

Read more ››
By: GlobeNewswire - 17 Apr 2024

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications

Read more ››
By: GlobeNewswire - 17 Apr 2024

IGM Biosciences Announces Refocusing of Sanofi Collaboration

Read more ››
By: GlobeNewswire - 17 Apr 2024

Mobile-health Network Solutions Ranked Number 41 in Financial Times Listing of 500 High-growth Asia-Pacific Companies

Read more ››
By: GlobeNewswire - 17 Apr 2024

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

Read more ››
By: GlobeNewswire - 17 Apr 2024

G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024

Read more ››
By: GlobeNewswire - 17 Apr 2024

Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)

Read more ››
By: GlobeNewswire - 17 Apr 2024

Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care

Read more ››
By: GlobeNewswire - 17 Apr 2024

Change in Leadership at AFB’s Journal of Visual Impairment & Blindness as Longtime Editor in Chief Sandra Lewis Steps Down, Robert Wall Emerson of Western Michigan University to Fill the Role

Read more ››
By: GlobeNewswire - 17 Apr 2024

Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects. 

Read more ››
By: GlobeNewswire - 17 Apr 2024

AAMI Releases Guidance on Dilator, Ultrasound DeSterilization

Read more ››
By: GlobeNewswire - 17 Apr 2024

Ipsen publishes its 2023 Universal Registration Document

Read more ››
By: GlobeNewswire - 17 Apr 2024

River Oaks Treatment Center is Setting the Standard for Clinical Excellence in Florida with Four Board-Certified Addiction Medicine Physicians

Read more ››
By: GlobeNewswire - 17 Apr 2024
Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate